Skip to main content

Press Releases

Press Releases

ArteraAI Prostate Test (Post-RP) Added to NCCN Guidelines

The addition builds on Artera’s inclusion in the guidelines for localized prostate cancer, extending decision support to pati [...]

Read more

Press Releases

Artera Earns Frost & Sullivan’s 2026 Technology Innovation Leadership Recognition for AI-Powered Breast Cancer Risk Stratification

Recognition highlights Artera's clinical evidence and its role in advancing precision oncology SAN FRANCISCO – October 29, 20 [...]

Read more

Press Releases

New Data Highlight Artera’s MMAI Consistency Across Diverse Patient Populations at ASTRO 2026

Five abstracts spanning global patient cohorts and U.S. cooperative trials reinforce the prognostic and predictive power of A [...]

Read more

Press Releases

Artera Presents Multiple ASCO 2026 Abstracts on Multimodal AI (MMAI) Risk Stratification and Treatment Decisions in Cancer

Validation of MMAI in node-positive HR+ breast cancer to determine chemotherapy benefit Concordance analysis between MMAI and [...]

Read more

Press Releases

Artera Expands Its Validated Multimodal AI Platform to Metastatic Hormone‑Sensitive Prostate Cancer (mHSPC)

First digital pathology-based test to provide individual risk estimates to help inform treatment planning in mHSPC SAN FRANCI [...]

Read more

Press Releases

Artera Receives U.S. FDA Clearance for ArteraAI Breast, Expanding Its AI Platform to Breast Cancer

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announ [...]

Read more

Press Releases

Artera Secures CE Marking for Its AI Prostate and Breast Cancer Assays, Unlocking Global Expansion

Dual regulatory milestones establish Artera as a global AI leader in precision oncology SAN FRANCISCO, April 21, 2026— Artera [...]

Read more

Press Releases

Artera Debuts ArteraAI Prostate Test (Post‑RP), Expanding its Oncology Portfolio

-Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, today announced the commercial launch of [...]

Read more

Press Releases

Artera Unveils Data Demonstrating Prognostic and Predictive Utility in Breast Cancer at SABCS 2025

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announ [...]

Read more

1 2 3 … 5